Carrie S. Cox

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Kenilworth, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/Megan Bombick, attorney-in-fact for Carrie S. Cox
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Carrie S. Cox

Form 4 holding Director

CARDINAL HEALTH INC

Security class
Common Shares
Shares / value
41,631
Estimated value
$4,457,847
Report date
09 Nov 2022
Price
$107.08
Ownership
Direct
Form 4 holding Director

Solventum Corp

Security class
Restricted Stock Units
Shares / value
4,848
Estimated value
$821,221
Report date
15 May 2026
Price
$71.51
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chair, Director

Organon & Co.

Security class
Phantom Stock
Shares / value
74,030
Estimated value
$743,258
Report date
13 Jun 2025
Price
$10.04
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chair, Director

Organon & Co.

Security class
Common Stock
Shares / value
77,869
Estimated value
$597,418
Report date
12 Nov 2025
Price
$7.67
Ownership
IRA
Form 4 holding Director

Cartesian Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
8,000
Estimated value
$6,320
Report date
02 Jan 2025
Price
$0.7900
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TEXAS INSTRUMENTS INC

Security class
NQ Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
13 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Carrie S. Cox

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .